Literature DB >> 17147507

Natural polymorphisms of HIV type 2 pol sequences from drug-naive individuals.

Ricardo Parreira1, Filipa Monteiro, Elizabeth Pádua, João Piedade, Teresa Venenno, Maria Teresa Paixão, Aida Esteves.   

Abstract

Until today, the susceptibility of human immunodeficiency virus type 2 (HIV-2) to protease and nucleosidic reverse-transcriptase inhibitors (PI and NRTI, respectively) has not been clearly documented. In this report we studied HIV-2 proviral sequences (n = 30) from drug-naive patients. Our results revealed that several amino acid positions in the protease and reverse transcriptase coding sequence harbored residues that have been associated with drug resistance in HIV-1-infected patients. In particular, the M46I substitution in the protease was detected in 90% of the sequences analyzed, which, together with the other substitutions identified, may indicate a reduced susceptibility of HIV-2-infected drug-naive patients to PI. Furthermore, interpretation of genotypic data with four available algorithms, developed for interpretation of HIV-1 sequence data, suggested nonoverlapping profiles of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147507     DOI: 10.1089/aid.2006.22.1178

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors.

Authors:  Delphine Desbois; Bénédicte Roquebert; Gilles Peytavin; Florence Damond; Gilles Collin; Antoine Bénard; Pauline Campa; Sophie Matheron; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

2.  Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.

Authors:  Jörg Schüpbach; Leslie R Bisset; Martin D Gebhardt; Stephan Regenass; Philippe Bürgisser; Meri Gorgievski; Thomas Klimkait; Corinne Andreutti; Gladys Martinetti; Christoph Niederhauser; Sabine Yerly; Stefan Pfister; Detlev Schultze; Marcel Brandenberger; Franziska Schöni-Affolter; Alexandra U Scherrer; Huldrych F Günthard
Journal:  BMC Infect Dis       Date:  2012-04-12       Impact factor: 3.090

3.  Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.

Authors:  Jörg Schüpbach; Martin D Gebhardt; Alexandra U Scherrer; Leslie R Bisset; Christoph Niederhauser; Stephan Regenass; Sabine Yerly; Vincent Aubert; Franziska Suter; Stefan Pfister; Gladys Martinetti; Corinne Andreutti; Thomas Klimkait; Marcel Brandenberger; Huldrych F Günthard
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

4.  Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

Authors:  Jean Ruelle; François Roman; Anne-Thérèse Vandenbroucke; Christine Lambert; Katrien Fransen; Fedoua Echahidi; Denis Piérard; Chris Verhofstede; Kristel Van Laethem; Marie-Luce Delforge; Dolorès Vaira; Jean-Claude Schmit; Patrick Goubau
Journal:  BMC Infect Dis       Date:  2008-02-27       Impact factor: 3.090

5.  Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.

Authors:  Jörg Schüpbach; Martin D Gebhardt; Zuzana Tomasik; Christoph Niederhauser; Sabine Yerly; Philippe Bürgisser; Lukas Matter; Meri Gorgievski; Rolf Dubs; Detlev Schultze; Ingrid Steffen; Corinne Andreutti; Gladys Martinetti; Bruno Güntert; Roger Staub; Synove Daneel; Pietro Vernazza
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.